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Background: Melanoma is the most fatal form of skin cancer 
due to its rapid metastasis. Recently, several studies re-
ported that selenium can induce apoptosis in melanoma cells. 
However, the precise mechanism remains to be elucidated. In 
this study, we investigated the effect of selenium on cell pro-
liferation in murine melanoma and on tumor growth and 
metastasis in C57BL/6 mice. Methods: Cell proliferation 
was measured by MTT assay in selenium-treated melanoma 
cells. Cell cycle distribution was analysized by staining DNA 
with propidum iodide (PI). mRNA and protein expression re-
lated to cell cycle arrest was measured by reverse tran-
scription PCR and western blot. Tumor growth and meta-
stasis was measured by in vivo model. Results: Selenium 
was suppressed the proliferation of melanoma cells in a dose 
dependent manner. The growth inhibition of melanoma by se-
lenium was associated with an arrest of cell cycle distribution 
at G0/G1 stage. The mRNA and protein level of CDK2/ 
CDK4 was suppressed by treatment with selenium in a 
time-dependent manner. In vivo, tumor growth was not sup-
pressed by selenium; however tumor metastasis was sup-
pressed by selenium in mouse model. Conclusion: These re-
sults suggest that selenium might be a potent agent to inhibit 
proliferative activity of melanoma cells.
[Immune Network 2009;9(6):236-242]
INTRODUCTION
Malignant melanoma is the most aggressive skin cancer due 
to its capacity to rapidly metastasize and strong resistance to 
anti-cancer therapy, such as chemotherapy and radiotherapy (1). 
In spite of extensively researched melanoma physiology, the 
associated rate of mortality is high and critical therapeutic ap-
proaches are still not sufficient. Several reports showed that 
treatment with antioxidants is more beneficial in preventing 
the rapid growth and metastasis of melanoma cells (2,3). In 
particular, the combination of anti-cancer drug and anti-oxi-
dant is more effective than single treatment because the com-
bination treatment leads to overall low toxicity via synergistic 
effect  (4). 
Selenium is an essential trace element involved in cellular 
homeostasis and protection against cellular stress such as ROS 
(reactive oxygen species) and DNA damage (5). Patrick et al., 
report that selenium has a function as an anti-cancer agent (6). 
Several reports demonstrate that sodium selenite, a source of 
selenium in many food supplements, can strongly induce cell 
death in various cancer cells (7-9). Additionally, recent stud-
ies reveal that sodium selenite display effective anti-cancer ac-
tivity against melanoma cancer cells. Despite much evidence 
about the anti-cancer and anti-oxidant effects of selenium, the 
exact  mechanism  whereby  this  chemical  induces  cell  death 
in  various  cancer  cells  is  not  yet  understand.
Recent studies revealed that ROS play a pivotal role in sele-
nium-mediated cancer cell death (10-12). The ROS level in-
crease cell death following treatment with selenium by induc-
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known that the CDK (cyclin-dependent kinase) has a critical 
role in ROS related cell cycle regulation. Some studies report 
that activation of p53 is induced by CDK2 gene expression 
upregulated by treatment with selenium, which then induces 
cell death in mouse mammalian epithelial carcinoma cell line. 
Moreover,  activation  of  p53  and  p38  pathway  has  been 
shown to induce apoptosis in human cervical cancer follow-
ing treatment with selenium (13-16). Although the effects of 
selenium on the growth and metastasis of some cancer cells 
are well known, the anti-cancer effects of selenium on cancer 
cell  growth  and  cell  migration  in  melanoma  are  not  com-
pletely understood. In this study, we evaluate the anti-cancer 
effects of selenium on a murine melanoma cell line and the 
anti-metastatic ability of selenium on an experimental meta-
stasis model using B16 mouse melanoma cells. These findings 
provide  useful  information  on  the  therapeutic  tool  of  anti-
oxidant  treatment  metastatic  melanoma  cancer. 
MATERIALS AND METHODS
Cell culture and reagents
B16F10, murine melanoma cell line, was maintained in RPMI 
1640  supplemented  with  2  mM  L-glutamine,  100  units/ml 
penicillin, 100 ug/ml streptomycin and 10% heat-inactivated 
fetal bovine serum. The cells were cultured at 37
oC in a hu-
midified atmosphere that contained 5% CO2. These cells were 
used  for  experiments  while  they  were  in  the  log  phase  of 
growth.  Sodium  selenite  (sele n i u m )  w a s  p u r c h a s e d  f r o m  
S i g m a  ( S t .  L o u i s ,  M O ,  U S A ) .
Assay for viable cells
The inhibition of cell growth was determined by 3 (4, 5-di-
methyl thiazolyl-2) 2, 5 diphenyl tetrazolium bromide (MTT; 
Sigma, St. Louis, MO, USA) assay. B16F10 mouse melanoma 
cells were seeded on 96 well plates (1×10
3 cells/well) and 
treated with 0, 1, 2, 10, 25, 50, or 100 uM selenium for 72 
hrs before adding 20 ul MTT solution (0.5 mg/ml). The MTT 
absorbance was measured at 570 nm using an ELISA reader 
(Bio-Tek instruments, Inc., Winnoski, VT, USA) 4 h after ad-
dition  of  the  dye.  Each  experiment  was  performed  in 
triplicate.
Detection of selenium- mediated apoptosis
To investigate the apoptosis-inducing effect of selenium, cells 
w e r e  c o l l e c t e d ,  w a s h e d  t w i c e  w i t h  P B S ,  a n d  t h e n  r e -
suspended  in  100  ul  of  Annexin  V  binding  buffer  (10  mM 
HEPES/NaOH pH 7.4, 140 mM N aCl, 2.5 mM CaCl 2). After 
2  ul  of  FITC-conjugated  Annexin  V  (BD  Pharmingen,  San 
Diego,  CA,  USA)  and  2  ul  of  propidium  iodide  (BD 
Pharmingen) were added, cells were incubated in the a dark 
room  at  room  temperature  for  15  minutes  with  gentle 
shaking. Finally, 400 ul of Annexin V binding buffer was add-
ed to each tube and cells were analyzed using a FACSCalibur 
(BD  Pharmingen).
Cell cycle analysis
Cell  cycle  analysis  was  performed  using  propidium  iodide 
(PI)-staining method. Cells were harvested after selenite treat-
ment, washed twice  in PBS  (2%  FBS), and  fixed with 70% 
cold  aqueous  ethanol  at  4
oC  o v e r n i g h t .  T h e  c e l l s  w e r e  r e -
suspended  in  a  PI  stain  (10  ug/ml  RNase  A  and  10  ug/ml 
PI in PBS) at room temperature for 30 minutes, and DNA con-
tent was determined using a FACSCalibur (BD Pharmingen).
Reverse-transcription polymerase chain reaction
To assess the effect of selenite on cell cycle regulatory gene 
expression, the cells were harvested after selenite treatment 
and washed twice in cold PBS. RNA was extracted using an 
RNeasy  mini  kit  (Quiagen,  Valencia,  CA)  according  to  the 
manufacturer’s  instructions,  and  RT  premix  (Bioneer,  Dae-
jeon,  South  Korea)  was  used  to  transcribe  cDNA.  RT-PCR 
analysis of specific gene transcript was carried out using the 
following  primers  for  p53  (upstream  primer;  5'-ATG  ACT 
GCC  ATG  GAG  GAG  T,  downstream  primer;  5'-CTC  GGG 
TGG  CTC  ATA  AGG  TA,  664-bp  product),  p21Waf1  (up-
stream primer; 5'-CTT TGA CTT CGT CAC GGA GAC, down-
stream primer; 5'-AGG CAG CGT GAA GGT GTT TGG GG, 
480-bp product), CDK2 (upstream primer; 5'-CAC AGC CGT 
GGA TAT CTG GAG, downstream primer; 5'-TTG CGA TAA 
CAG GCT CCG TC, 253-bp product), CDK4 (upstream primer; 
5'-ACG  CCT  GTG  GTG  GTT  ACG  CT,  downstream  primer; 
5'-CCA  TCT  CTG  GCA  CCA  CTG  AC,  280-bp  product).  β
-actin  (upstream  primer;  5'- A A G  A G C  T A T  G A G  C T G  C C T  
GA, downstream primer; 5'-CAG GAG GAG CAA TGA TCT 
T G ,  3 0 0 - b p  p r o d u c t )  w a s  u s e d  a s  a n  i n t e r n a l  c o n t r o l .  P C R 
(24cycle; 30 seconds at 94
oC, 30 seconds at 60
oC, 60 seconds 
at  72
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Figure 1. Effect of selenium on cell viability and morphological 
changes of B16F10 murine melanoma cells. (A) Selenium inhibits cell
viability of B16F10 murine melanoma cells (MTT assay). B16F10 
melanoma cells (1×10
3) were seeded onto a 96-well plate and treated
with various doses (0. 1, 5, 10, 25, 50 and 100 uM) of selenium for 
72 hr. MTT solution (100 ug/ well) was added to the cells 4 hr later. 
(B) B16F10 cells (2×10
5) were seeded onto a 6-well plate overnight
to undergo attachment and then treated with various doses (0, 10, 20,
and 40 uM) of selenium. After 48 h, photos of cells were taken with 
an inverted microscope.
Korea) on ice for 30 min. Each cell lysate was separated by 
15% SDS-PAGE under reducing conditions and transferred to 
a nitrocellulose membranes using semidry technique at 80mA 
for 2 hours. The blots were blocked with 5% skim milk in 
PBS for 1 hour, and subsequently incubated with primary an-
tibodies (Abs) at a final dilution of 1：1,000 for 2 hour. After 
three  washes  in  PBST  (0.05%  tween-20  in  PBS),  blot  were 
incubated  with  peroxidase-conjugated  secondary  antibodies 
(final dilution, 1：3,000) in dilution buffer (5% skim milk in 
P B S )  f o r  1  h o u r  a n d  t h e n  w a s h e d  a s  d e s c r i b e d  a b o v e .  
Detection  was  performed  by  chemiluminescence  using  an 
ECL-kit  (Enhanced  Chemi  Luminescence;  Amersham  Life 
Science, Braunschweig, Germany) and the Multiple Gel-DOC 
system (Fujifilm, Tokyo, Japan). The following primary anti-
bodies were used: p21 Waf1/Cip1, CDK4, CDK2 and β-actin 
from  Cell  Signaling  (Beverly,  MA,  USA).
Animal and experimental metastasis assay
Six- to 8-week-old C57BL/6 mice were obtained from Orient 
(Seoul, Korea). The institutional review board of animal ex-
periments  reviewed  all  animal  studies.  Six-  to  8-week-old 
C57BL/6 mice were injected with 0.1 ml of PBS containing 
0.1  million  B16F10  cells  by  intra-optic  venous  route.  Mice 
were  randomly  assigned  to  5  groups  (5  mice/group).  The 
mice were treated from day 1 onward with 10 uM selenium 
through intraperitoneal route. On days 4 and 8 the mice re-
ceived selenium in 200μl PBS injected i.p. The mice were 
killed on day 14, and melanotic colonies on the surface of 
the lung were counted. The lung sections were fixed, stained 
with hematotoxylin-eosin (H&E) and was observed under a 
phase  contrast  microscope. 
Statistical analysis
Results  are  representative  of  at  least  three  separate  experi-
ments. Statistical significance was calculated using Student's 
t-test.  p  values  less  than  0.05  were  considered  significant.
RESULTS
Effects of the selenium on B16F10 cell growth and 
cellular morphology
To  assess  whether  selenium  directly  induces  cell  death  of 
B16F10 melanoma cells, cells were treated with 0, 1, 2, 10, 
25, 50, or 100 uM of selenium. Selenium-induced inhibition 
of cell growth was determined by MTT assay. Fig. 1A shows 
that the growth of cells exposed to 50 uM selenium for 72 
hour was significantly reduced to 35% of control group. We 
also  found that selenium inhibited  the growth  of cells  in a 
dose-dependent manner. To confirm our result, we observed 
the morphological changes of B16F10 cells exposed to 40 uM 
selenium  at  24  hours  and  48  hours.  As  shown  in  Fig.  1B, 
treatment with 40 uM selenium significant decreased the cell 
number  of  B16F10  melanoma  cells  in  a  time-dependent 
manner.
Effects of the selenium on B16F10 cell death and 
cell cycle
N e x t ,  w e  m e a s u r e d  a p o p t o s i s  o f  B 1 6 F 1 0  c e l l s  b y  f l o w - c y -
tometry  analysis.  Cell  cultures  were  treated  under  various 
conditions for 72 hours. Fig. 2A shows that treatment with Selenium Induces Cell Death of Murine Melanoma Cells
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Figure 2. Selenium-induced cell death and cell cycle arrest of B16F10 murine melanoma cells. (A) B16F10 melanoma cells (2x10
5) were seeded
onto a 6-well plate overnight to undergo attachment. Cells were exposed to selenium (0, 10, 20, and 40 uM) and then incubated for 48 hr. 
After incubation, cells were harvested with cell dissociation solution and washed once with PBS. The cytotoxic effect of selenium on B16F10 
melanoma cells was assessed by Annexin-V-FITC/PI staining. Cell death analysis was performed by flow cytometry. The numbers indicate the 
percentages of the viable (Annexin-V −; PI −) cell population (lower left quadrant), the apoptotic (Annexin V＋) cell population (lower right
quadrant), and the necrotic cell populations in the upper right (Annexin-V ＋; PI ＋) and the upper left quadrants (Annexin-V −; PI ＋). (B) 
B16F10 melanoma cells were treated with selenium (0, 10, 20, and 40 uM) and then incubated for 48 hr. Cells were harvested with cell 
dissociation solution, washed twice with cold PBS, and centrifuged. The pellet was resuspended in 1 ml of cold PBS and 4 ml of cold ethanol
for 30 min at 4
oC. Cells were then stained with propidium iodide 30 min and analyzed by flow cytometry. Percentages of G0/G1-, S-, and 
G2/M- phase cells are shown in this figure.
selenium induces apoptosis in B16F10. The number of apop-
totic cells following treatment with 40 uM selenium was sig-
nificantly  higher  as  compared  with  the  low-dose  treated 
group.
To determine the mechanism of selenium-induced apopto-
sis,  we  analyzed  the  cell  cycle  of  selenium  treated  B16F10 
by PI staining method. Addition of sodium selenium (40 uM) 
significantly increased the G0/G1 arrest in B16F10 cells com-
pared with the low-dose treated group (Fig. 2B). Taken to-
gether, these results indicate that G0/G1 cell cycle arrest is 
dominantly  involved  in  selenium-induced  apoptosis. 
Effects of the selenium on expression of cell cycle 
regulator molecules in B16F10 melanoma cells
In  order  to  examine  the  mechanism  of  selenium-induced 
G0/G1 arrest in B16F10 cells, we investigated the mRNA and 
protein  expression  pattern  of  various  cell  cycle  regulators 
such as p53, p21Waf1, CDK2 and CDK4 after treatment with 
selenium. As shown in Fig. 3A, treatment with selenium sig-
nificantly  decreased  expression  of  p53,  CDK2  and  CDK4 
mRNA in time-dependent manner. However, p21Waf1 mRNA 
was  increased  in  a  time-dependent  manner  following  treat-
ment (Fig. 3A). Furthermore, after exposing cells to 40 uM 
selenium,  the  protein  level  of  p21WAF1  significantly  in-
creased, while protein levels of CDK2 and CDK4 decreased 
in time-dependent manners (Fig. 3B). This result implies that 
selenium- induced cell cycle arrest is regulated by a p53-in-
dependent  p21Waf1  pathway. Selenium Induces Cell Death of Murine Melanoma Cells
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Figure 3. The effect of selenium on the expression of cell cycle arrest
related genes in B16F10 melanoma cells. (A) B16F10 melanoma cells
were harvested at the indicated times after incubation with selenium 
(40 uM). Total RNA was extracted from cells at 48 hr and cDNA was
prepared using methods described in the Material and Methods 
section. (B) B16F10 melanoma cells were harvested at the indicated 
times after incubation with selenium (40 uM). The cells were then 
lysed, and the supernatants were subjected to western blot analysis 
and immunoblotted with anti-p21Waf1/Cip1, anti-CDK4, and anti- 
CDK2 antibodies.
Figure 4. The effect of selenium on tumor growth. B16F10 melanoma
cells were injected s.c. into mice. Selenium was injected at the tumor
site. Selenium was then injected 2 more times in 4-day-period. Tumor 
size was measured every other day by a vernier calipers.
Effects of selenium on tumorigenesis and B16F10 
metastasis to mouse lung
Treatment with selenium regulated p53-independent pathway 
and cell growth, which are both related to tumor cell growth. 
To evaluate the effect of selenium on melanoma cell growth, 
the in vivo growth of melanoma cells in C57BL/6 mouse was 
determined after the subcutaneous inoculation of B16F10 cells 
a n d  t r e a t m e n t  w i t h  s e l e n i u m .  W h e n  s e l e n i u m  w a s  a d -
ministered syngeneic mice, severe regression of tumor growth 
was not observed (Fig. 4). However, B16F10 melanoma-bear-
ing  mice  treated  with  selenium h a d  a  s i g n i f i c a n t l y  r e d u c e d  
tumor burden as measured by counting the number of lung 
colonies (Fig. 5A). Additionally, we tested for lung metastatic 
tumor cells to B16F10 bearing mice using histochemical H&E 
staing. As shown in Fig. 5B and C, treatment with selenium 
significant decreased the number of lung metastatic spots by 
B16F10 melanoma cells. These results demonstrate that sele-
nium promotes anti-cancer activity and anti-metastasis activity 
in  melanoma  cell  bearing  mice.
DISCUSSION
One of the most important problems with removing melano-
ma  is  its  powerful  metastatic  tumor  growth.  In  the  present 
study, we have evaluated the effect of selenium on control-
ling B16F10 melanoma proliferation and metastasis. It is well 
known  that  anti-oxidant  compounds,  such  as  ascorbic  acid 
and selenium, have the ability to inhibit cancer growth and 
metastasis (2,3). Selenium compound has been specifically re-
ported to significantly reduce cell proliferation and incidence 
of cancer in vivo by being added to in vitro cell culture or 
s u p p l e m e n t e d  i n  a n i m a l  d i e t s  ( 6 ) .  H o w e v e r ,  t h e  d e t a i l e d  
mechanism  of  its  anti-cancer  and  anti-metastatic  effects  re-
mains  poorly  understood. 
W e  e v a l u a t e d  t h e  e f f e c t s  o f  s e l e n i u m  o n  t h e  l u n g  m e t a-
stasis of B16F10 melanoma cells in vivo. Interestingly, our re-
sults show that the selenium-treated group had reduced meta-
stasis of B16F10 melanoma cells, although treatment with se-
lenium did not reduce the tumorigenesity of B16F10 melano-
ma cells (Fig. 4, 5). To identify the affects of selenium on 
the relationship of tumorigenesity and metastasis in B16F10 
melanoma cells, treated cells were analyzed for changes in 
cell morphology and apoptosis (Fig. 1, 2). Treatment with se-
lenium  led  to  morphologic  changes  in  B16F10  melanoma Selenium Induces Cell Death of Murine Melanoma Cells
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Figure 5. The effect of selenium on metastasis to lung. Affect of intra-peritoneal treatment with 100 uM selenium on B16F10 experimental metastasis
to lung (A) Representative photos of the lungs. Cells were injected through intra-optic venous. After 14 days mice were killed and the pulmonary
nodules of B16F10 melanoma were counted. (B) Representative hematoxylin and eosin staining sections of the lungs were photographed. The 
arrows point to the metastatic tumors in lung. The area of the lung occupied by the colonies in the histology sections was measured 
microscopically. (C) The number of lung metastatic tumor. 
cells  and  increase  in  apoptotic  events  in  a  dose-dependent 
manner. These results suggest that significant anti-metastatic 
activity of sodium selenite may be due to the apoptotic activ-
ity  of  selenium.
More interestingly, our results revealed that cell apoptosis 
of B16F10 melanoma cells mediated G0/G1 arrest following 
treatment with selenium. This is significant because it is well 
known that regulation of the cancer cell cycle is one of the 
therapeutic  targets  for  identification  of  new  anti-cancer 
strategy. Of particular importance are disruptions of cell cycle 
at  the  G0/G1  check-point,  which  leads  to  dis-regulation  of 
tumor growth (17-21). Based on this evidence, we focused 
on the mechanism of G0/G1 cell cycle arrest in selenium-in-
duced apoptosis. Many studies have reported that p53 is in-
volved  in G0/G1 cell cycle arrest (22-25).  However, Deeds 
et  al.  recently  observed  that  G0/G1  arrest  is  induced  in  a 
p53-independent manner (26). As shown in Fig. 3, our results 
support the findings that selenium induces G0/G1 arrest via 
p53-independent  pathway  through  expression  of  p21Waf1. 
Several studies have revealed that p21WAF1 has a critical role 
in the mechanism of G0/G1 arrest, which involves association 
of  CDK-cyclin  complex  to  inhibit  CDK  kinase  activity  (27). 
We found that treatment of melanoma with sodium selenium 
induces expression of p21WAF1, which leads to down-regu-
lation of CDK4 and CDK2 expression at the mRNA and pro-
t e i n  l e v e l s  ( F i g .  3 ) .  O u r  f i n d i n g s  s u g g e s t  t h a t  s e l e n i u m  i n -
duces cell apoptosis due to G0/G1 arrest through a p53-in-
dependent  p21WAF1  pathway. 
In conclusion, we suggest that treatment with selenium en-
hances the ability of anti-metastasis to promote apoptosis of 
B16F10 melanoma cells by inducing p53-independent G0/G1 
cell cycle arrest. Further knowledge regarding the treatment 
of selenium may provide a usefully concept for therapy strat-
egy  to  improve  malignancy  in  cancer  patients.
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